关于急性髓性白血病的现状和研究方向
Hagop Kantarjian1, Gautam Borthakur2, Naval Daver2
1From the Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA. hkantarjian@mdanderson.org.
Blood cancer journal
|September 19, 2024
概括
急性髓性白血病 (AML) 治疗的最新进展包括自2017年以来批准的12种新的向疗法. 本综述更新了这种罕见癌症的标准护理和研究治疗方法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性髓性白血病 (AML) 是一种罕见且异质的血液癌症.
- 了解AML的分子病理生物学导致了新的向疗法.
- 在开发和批准新的AML治疗方法方面取得了重大进展.
研究的目的:
- 为AML提供标准护理和研究治疗方法的最新审查.
- 概述AML治疗中的有希望的当前和未来研究方向.
- 突出AML治疗的复杂性,需要专业知识和专业护理.
主要方法:
- 关于AML治疗的最新文献的审查.
- 分析已批准的向剂及其机制.
- 讨论新兴的治疗策略和正在进行的研究.
主要成果:
- 自2017年以来批准的12种新药用于AML子集,包括BCL2,FLT3和IDH抑制剂.
- 低甲基化剂和组合疗法 (例如,CPX-351) 的新配方可用.
- 新兴疗法,如脑膜抑制剂和CD123抗体-药物联合体,显示出有希望的结果.
结论:
- 在AML治疗的景观已经迅速演变,许多向疗法.
- 最佳的洗钱防治需要专业的专业知识和获得各种治疗方案.
- 持续的研究对于进一步改善急性髓性白血病的结果至关重要.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.2K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K